Oppenheimer Asset Management Inc. Buys 7,385 Shares of Doximity, Inc. (NASDAQ:DOCS)

Oppenheimer Asset Management Inc. increased its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 48.2% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 22,705 shares of the company’s stock after purchasing an additional 7,385 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Doximity were worth $635,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of DOCS. Norges Bank bought a new position in Doximity during the fourth quarter valued at $35,995,000. Blair William & Co. IL grew its holdings in Doximity by 31.7% during the 1st quarter. Blair William & Co. IL now owns 90,600 shares of the company’s stock valued at $2,438,000 after purchasing an additional 21,787 shares during the last quarter. Edmond DE Rothschild Holding S.A. raised its position in Doximity by 15.1% in the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 2,302,240 shares of the company’s stock worth $64,555,000 after purchasing an additional 301,290 shares during the period. Pinebridge Investments L.P. bought a new stake in Doximity in the fourth quarter worth about $2,845,000. Finally, Acadian Asset Management LLC boosted its position in shares of Doximity by 128.7% during the first quarter. Acadian Asset Management LLC now owns 96,442 shares of the company’s stock valued at $2,590,000 after buying an additional 54,281 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

DOCS has been the subject of a number of research analyst reports. Wells Fargo & Company lowered Doximity from an “equal weight” rating to an “underweight” rating and decreased their price target for the stock from $27.00 to $19.00 in a research note on Thursday, July 18th. Bank of America boosted their target price on shares of Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research note on Friday, August 9th. Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a research note on Friday, August 9th. Evercore ISI boosted their price objective on shares of Doximity from $29.00 to $34.00 and gave the company an “in-line” rating in a research report on Friday, August 9th. Finally, Baird R W raised shares of Doximity to a “strong-buy” rating in a research note on Tuesday. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $32.42.

Doximity Trading Up 0.6 %

Shares of NASDAQ:DOCS opened at $40.89 on Friday. The company has a market capitalization of $7.58 billion, a PE ratio of 56.79, a P/E/G ratio of 5.15 and a beta of 1.27. Doximity, Inc. has a 12-month low of $19.71 and a 12-month high of $41.05. The business’s fifty day simple moving average is $33.20 and its 200-day simple moving average is $29.00.

Doximity (NASDAQ:DOCS) last announced its earnings results on Thursday, August 8th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.06. The business had revenue of $126.68 million during the quarter, compared to the consensus estimate of $119.88 million. Doximity had a net margin of 32.53% and a return on equity of 19.26%. Research analysts predict that Doximity, Inc. will post 0.8 EPS for the current year.

Insider Activity at Doximity

In other Doximity news, CFO Anna Bryson sold 30,000 shares of Doximity stock in a transaction on Friday, August 9th. The shares were sold at an average price of $35.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at $10,836,945. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Doximity news, CFO Anna Bryson sold 30,000 shares of the firm’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the completion of the sale, the chief financial officer now owns 309,627 shares of the company’s stock, valued at $10,836,945. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Watkin Phoebe L. Yang sold 1,940 shares of the business’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $28.22, for a total value of $54,746.80. Following the sale, the director now owns 12,269 shares in the company, valued at approximately $346,231.18. The disclosure for this sale can be found here. Insiders sold 37,951 shares of company stock valued at $1,271,018 over the last 90 days. Insiders own 39.40% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.